Monsanto moves to gene editing – The Australian
The Australian |
Monsanto moves to gene editing
The Australian Over the past year, Monsanto has licensed two different Crispr versions, Crispr-Cas and Crispr–Cpf1, as well as the Exzact technology and another gene-editing platform developed by TargetGene Biotechnologies. The company has recruited medical and … |
